Abbott | ABT - Umsatzkosten

Aktienkurs
90.79
Täglich Wechseln
-0.54 -0.59%
Monatlich
-11.57%
Jährlich
-30.63%
Q2 Prognose
89.18




Umsatzkosten Veränderung Datum
Abbott USD 5.3B 380M 2026-03
Agilent USD 852M 19M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 376.8M 87.4M 2025-12
Danaher USD 2.36B 512M 2026-03
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Smith & Nephew USD 870M 17M 2025-12
Solventum Corp USD 971M 8M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03